• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Should we start getting worried?





THIS IS SOOOOOOO SAD! Why in the world would you Come to cafe pharma to seek information about this "drug launch" (not happening anytime soon) from folks in THE SAME CLUELESS, INFORMATION-LESS, HELL I DONT KNOW EITHER Boat?!

Think practically, if Teva really knew WHEN this "me too" was launching, they would tell YOU THE SALESFORCE! The fact you and everyone wlse in this thread knows squat, outta make you wake up and realize that:

A) real time is passing you buy
B) that other qualified and real sales jobs are out there and available
C) it's really sad to hold onto hopes of a job with nooooooooooo updated communication from corporate

PLEASE WAKE UP AND MOVE ON!!!!!

Amen!!!!
 












Went from December launch to first quarter, now next quarter?

NOONE on cafe pharma knows anything...anyone who comes here looking for info is misguided. Wait for an email from the "manager"

I was told this morning by my hiring manger that although not official, he doesn't see the expansion happening until April.
 
























































What a laughing stock this entire division has become. Managers are shaking in their boots...several of them will not receive their promotions if this drug doesn't take off as several managers are part of the "expansion." Zecuity is an expensive headache pill in a dollar store patch. But hey, it could be worse...you could be working in the Teva Respiratory division.